|
COPYRIGHT 2003 International Medical News Group
MANCHESTER, ENGLAND -- Sustained use of the tumor necrosis factor-[alpha] inhibitor infliximab appears effective in the treatment of Behcet's syndrome, Dr. Cristina Estrach said at the annual meeting of the British Society for Rheumatology.
As experience with anti--tumor necrosis factor-[alpha]. (anti-TNF-[alpha]) drugs in conditions such as rheumatoid arthritis and Crohn's disease...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
